Search results

Found 1,514 pages
AUTHOR: Anna Smith

Results per page

10 20 50 100

Sort by

Relevance Date

19 Jun 2019:

NICE nod for Blincyto

Amgen has a confidential commercial arrangement which will make the drug available to the NHS with a discount. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/nice_nod_for_blincyto_1291867

26 Mar 2019:

EU approves AZ' Forxiga for type I diabetes

The drug is the first oral medicine approved in Europe as an adjunct to insulin for adults with type I diabetes. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/eu_approval_for_forxiga_1282611

12 Mar 2020:

COVID-19: NHS ‘ramp up’ testing labs as outbreak declared pandemic

As well as testing of people who meet the criteria for being at risk, the NHS and PHE are also carrying out surveillance testing on people in wards and surgeries showing signs of the virus. - News - PharmaTimes

by Anna Smith|Anna Smith

https://www.pharmatimes.com/news/covid-19_nhs_ramp_up_testing_labs_as_outbreak_declared_pandemic_1329028

26 Feb 2020:

Takeda acquires PvP Biologics

The acquisition follows the conclusion of a Phase I proof-of-mechanism study of investigational medicine TAK-062. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/takeda_acquires_pvp_biologics_1327012

24 Mar 2020:

COVID-19: Gilead deals with ‘overwhelming’ remdesivir demands, Eli…

The current recorded case count for COVID-19 (coronavirus) in the UK has hit 6,650, with 335 deaths and 135 recoveries. - News - PharmaTimes

by Anna Smith|Anna Smith

https://www.pharmatimes.com/news/covid-19_gilead_deals_with_overwhelming_remdesivir_demands,_eli_lilly_halts_trial_enrolment_1329883

30 Sep 2019:

Suliqua launches in UK

The approval is based on two phase III studies, LixiLan-O and LixiLan-L. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/suliqua_launches_in_uk_1311439

27 Mar 2019:

Novartis' MS drug gets FDA approval

The FDA has approved Novartis’ multiple sclerosis drug, Mayzent. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/novartis_ms_drug_gets_fda_approval_1282734

13 Sep 2019:

FDA approves Nucala

The treatment was also recently made available in two new formulations in the UK, a pre-filled pen and a pre-filled syringe. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/fda_approves_nucala_1301560

15 Mar 2019:

Uveal melanoma study announced

Researchers have announced a study to identify new treatments for uveal melanoma. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/uveal_melanoma_study_announced_1281688

16 Aug 2019:

Rozlytrek bags FDA approval

For the indication of ROS1-positive, metastatic non-small cell lung cancer (NSCLC). - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/rozlytrek_bags_fda_approval_1297771